Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 3 of 3 Clinical Trials
ID/Name Source Type
18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
NCT02031198 clinicaltrials.gov Clinical Trial
24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease
NCT02579252 clinicaltrials.gov Clinical Trial
Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
NCT01850238 clinicaltrials.gov Clinical Trial